Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

BACKGROUND: Galectin‐3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non‐small cell lung cancer (NSCLC). However, the prognostic impact of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thorac Cancer
Autori principali: Kusuhara, Seiichiro, Igawa, Satoshi, Ichinoe, Masaaki, Nagashio, Ryo, Kuchitsu, Yuki, Hiyoshi, Yasuhiro, Shiomi, Kazu, Murakumo, Yoshiki, Saegusa, Makoto, Satoh, Yukitoshi, Sato, Yuichi, Naoki, Katsuhiko
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons Australia, Ltd 2021
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107024/
https://ncbi.nlm.nih.gov/pubmed/33793071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13945
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi